Micro Emerging Active

UroGen insider sells after 191% stock run

New narrative with limited coverage — still forming.

Score
0.2
Velocity
▲ 0.0
Articles
1
Sources
1

Sentiment Timeline

Event Timeline

Jul 12, 2026
UroGen's Chief Medical Officer Sold $400,000 in Stock After a 191% Run Neutral

Timeline

Last UpdatedJul 12, 2026